Northern Trust’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Northern Trust’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-350,530	Closed	-$6.99M	–	4775
2022 Q3	$6.99M	Buy	350,530 +3,540	+1%	+$46.7K	﹤0.01%	2240
2022 Q2	$2.39M	Buy	346,990 +36,174	+12%	+$254K	﹤0.01%	2957
2022 Q1	$2.89M	Sell	310,816 -2,293	-0.7%	-$24.4K	﹤0.01%	2900
2021 Q4	$4.45M	Buy	313,109 +7,330	+2%	+$127K	﹤0.01%	2758
2021 Q3	$7.09M	Buy	305,779 +17,724	+6%	+$419K	﹤0.01%	2515
2021 Q2	$7.17M	Sell	288,055 -8,998	-3%	-$242K	﹤0.01%	2599
2021 Q1	$8.32M	Buy	297,053 +92,156	+45%	+$3.33M	﹤0.01%	2417
2020 Q4	$7.15M	Buy	204,897 +18,565	+10%	+$808K	﹤0.01%	2462
2020 Q3	$9.29M	Buy	+186,332	New	+$7.53M	﹤0.01%	2154

Northern Trust's FMTX Position: Q4 2022 in Review

Northern Trust sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 350,530 shares — an estimated $6.99M sold.

Northern Trust first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $9.29M in Q3 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Northern Trust reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Northern Trust sold 350,530 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $6.99M.
Northern Trust first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
Northern Trust's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $9.29M in Q3 2020.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.